Clearmind Medicine (NASDAQ: CMND) (CSE: CMND) has received patent approval in China for a new type of psychedelic substance-based treatment that targets binge behaviors. The approval the biotech company — which operates out of Tel Aviv, Israel, and Vancouver, Canada — received is for a broad claim related to the …
German cannabis pharmaceutical Avextra AG has successfully completed a new round of funding, the company announced Wednesday. The company has now raised over 20 million euros in the past 18 months through selling company shares and convertible loans, which now have all been turned into common shares, valuing the company …
The Daily Hit is a recap of the top financial news stories for Feb. 6, 2024. On the Site Planet 13 sues Casa Verde in sprawling cannabis financial dispute A financial battle royale among at least eight different cannabis stakeholders – which has been building to a crescendo since it …
Curaleaf International, a division of Curaleaf Holdings (OTCQX: CURLF) (TSX:CURA) is buying Can4Med, a prominent pharmaceutical wholesaler specializing in cannabinoid medications in Poland. Curaleaf had noted in its last MD&A that it planned to continue investing internationally, to expand its vertically integrated presence in major medical-use markets across Europe and best position itself …